Fig. 8From: Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databasesComparison of risk of new-onset diabetes mellitus among moderate-intensity statins. A all doses of pitavastatin vs. moderate-intensity atorvastatin, B all doses of pitavastatin vs. moderate-intensity rosuvastatin. *Incidence rate per 1000 person-yearsBack to article page